Revance Therapeutics Inc (RVNC) USD0.001

Sell:$3.74Buy:$3.88$0.02 (0.53%)

NASDAQ:2.05%
Market closed | Prices delayed by at least 15 minutes
Sell:$3.74
Buy:$3.88
Change:$0.02 (0.53%)
Market closed | Prices delayed by at least 15 minutes
Sell:$3.74
Buy:$3.88
Change:$0.02 (0.53%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
16 April 2024
Erica JordanChief Legal/Compliance Officer
Sell
Tax related
2,392$3.80$9,096.30114,864
18 March 2024
Tobin SchilkeCFO
Sell
Tax related
9,361$5.04$47,203.78192,666
18 March 2024
Dustin S SjutsPresident
Sell
Tax related
9,211$5.04$46,446.47167,550
18 March 2024
Dwight MoxieCompany Secretary
Sell
Tax related
8,125$5.04$40,971.13137,815
15 March 2024
Mark J FoleyCEO
Sell
Tax related
3,305$5.31$17,533.031,012,163
15 March 2024
Mark J FoleyCEO
Sell
Tax related
17,228$5.31$91,394.54994,935
15 March 2024
Tobin SchilkeCFO
Sell
Tax related
3,822$5.31$20,275.71202,027
15 March 2024
Dustin S SjutsPresident
Sell
Tax related
2,967$5.31$15,739.94176,761
15 March 2024
Dwight MoxieCompany Secretary
Sell
Tax related
3,269$5.31$17,342.05145,940
6 March 2024
Mark J FoleyCEO
Buy
Regular purchase transaction
30,000$6.98$209,400.001,015,468

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
15 May 2023
Mark J FoleyCEO
Sell
Tax related
70,447$34.55$2,433,725.46923,212
9 June 2023
Mark J FoleyCEO
Sell
Regular sell transaction (market)
31,279$30.72$960,928.41891,933
11 August 2023
Mark J FoleyCEO
Sell
Tax related
48,064$18.91$908,890.24914,454
15 May 2023
Tobin SchilkeCFO
Sell
Tax related
21,401$34.55$739,338.2184,029
15 May 2023
Dwight MoxieCompany Secretary
Sell
Tax related
21,401$34.55$739,338.2169,165

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.